View:
Mini BasicThis view is available after user registration.
ShortThis view is available when you buy a license.
StandardThis view is available when you buy a license.
CompleteThis view is available when you buy a license.
Trastuzumab Emtansine 3.6, Tumor Biomarker Defined
Protocol-ID: 1677 V1.0 (Mini), TRASEM3,6, Tumor Biomarker DefinedIndication(s)
- Tumor Biomarker Defined (HER2+)
 | The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti. |
Valid since: 12.02.2021